(Q46898523)
English
Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Gr
scientific article published in February 2006
Statements
1 reference
Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Gr (English)
1 reference
1 reference
Pieter Sonneveld
1 reference
William R Friedenberg
1 reference
Montserrat Rue
1 reference
Emily A Blood
1 reference
William S Dalton
1 reference
Chaim Shustik
1 reference
Philip R Greipp
1 reference
1 February 2006
1 reference
1 reference
106
1 reference
4
1 reference
830-838
1 reference
Identifiers
1 reference
1 reference